{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:15:23Z","timestamp":1786990523276,"version":"build-2736575974"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360701"],"award-info":[{"award-number":["82360701"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32471251"],"award-info":[{"award-number":["32471251"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32501075"],"award-info":[{"award-number":["32501075"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009666","name":"Salt Science Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["2025GXNSFDA04240002"],"award-info":[{"award-number":["2025GXNSFDA04240002"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["BL10U2"],"award-info":[{"award-number":["BL10U2"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ijbiomac.2026.150689","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T15:47:41Z","timestamp":1770047261000},"page":"150689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Crystallographic fragment screening discovers novel micromolar active inhibitors and druggable hotspots of SARS-CoV-2 PLpro"],"prefix":"10.1016","volume":"347","author":[{"given":"Wei-wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-qing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-min","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-liu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-hao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.150689_bb0005","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(03)14630-2","article-title":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People\u2019s Republic of China, in February, 2003","volume":"362","author":"Zhong","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jcv.2003.09.011","article-title":"Severe acute respiratory syndrome (SARS)\u2014paradigm of an emerging viral infection","volume":"29","author":"Berger","year":"2004","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0015","doi-asserted-by":"crossref","first-page":"152","DOI":"10.7861\/clinmedicine.4-2-152","article-title":"Severe acute respiratory syndrome (SARS): a review","volume":"4","author":"Vijayanand","year":"2004","journal-title":"Clin. Med."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0020","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev-med-051215-031152","article-title":"Middle East Respiratory Syndrome: Emergence of a Pathogenic Human Coronavirus","volume":"68","author":"Fehr","year":"2017","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0025","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00705-014-1995-5","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV): evidence and speculations","volume":"159","author":"Abdel-Moneim","year":"2014","journal-title":"Arch. Virol."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0030","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10096-017-3144-z","article-title":"Epidemiology and clinical characteristics of human coronaviruses OC43, 229E, NL63, and HKU1: a study of hospitalized children with acute respiratory tract infection in Guangzhou, China","volume":"37","author":"Zeng","year":"2018","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0035","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1128\/JCM.00636-10","article-title":"Epidemiology and Clinical Presentations of the Four Human Coronaviruses 229E, HKU1, NL63, and OC43 Detected over 3 Years Using a Novel Multiplex Real-Time PCR Method","volume":"48","author":"Gaunt","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0040","first-page":"46","article-title":"The SARS-CoV-2 Coronavirus and the COVID-19 Outbreak","author":"Lauxmann","year":"2020","journal-title":"Int. Braz. J. Urol."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0045","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s12063-021-00179-y","article-title":"Disruption in global supply chain and socio-economic shocks: a lesson from COVID-19 for sustainable production and consumption","volume":"15","author":"Yu","year":"2022","journal-title":"Oper. Manag. Res."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0050","article-title":"The Impact of the COVID-19 Pandemic on Social, Health, and Economy","author":"Clemente-Su\u00e1rez","year":"2021","journal-title":"Sustainability"},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0055","first-page":"13","article-title":"SARS-CoV-2 Evolution: Implications for Diagnosis, Treatment","author":"Angius","year":"2024","journal-title":"Vaccine Effectiveness and Development. Vaccines"},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0060","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02979-21","article-title":"The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines","volume":"13","author":"McLean","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/joim.13478","article-title":"Advances in the Omicron variant development","volume":"292","author":"Vitiello","year":"2022","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0070","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41569-021-00640-2","article-title":"Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective","volume":"19","author":"Halawa","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0075","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(22)00519-0","article-title":"Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses","volume":"399","author":"QA","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0080","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo0718","article-title":"Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms","volume":"14","author":"Stevens","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0085","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/cid\/ciac180","article-title":"Molnupiravir and Nirmatrelvir-Ritonavir: Oral Coronavirus Disease 2019 Antiviral Drugs","volume":"76","author":"Saravolatz","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0090","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbrc.2022.09.010","article-title":"Hotspot residues and resistance mutations in the nirmatrelvir-binding site of SARS-CoV-2 main protease: Design, identification, and correlation with globally circulating viral genomes","volume":"629","author":"Padhi","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0095","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41586-024-08320-0","article-title":"Small-molecule inhibition of SARS-CoV-2 NSP14 RNA cap methyltransferase","volume":"637","author":"Meyer","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0100","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92641-x","article-title":"Natural variants in SARS-CoV-2 Spike protein pinpoint structural and functional hotspots with implications for prophylaxis and therapeutic strategies","volume":"11","author":"Pokhrel","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0105","doi-asserted-by":"crossref","first-page":"7561","DOI":"10.1021\/acs.jmedchem.2c00303","article-title":"Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease","volume":"65","author":"Tan","year":"2022","journal-title":"J. Med. Chem."},{"issue":"2022","key":"10.1016\/j.ijbiomac.2026.150689_bb0110","article-title":"Inhibitors of SARS-CoV-2 PLpro. Frontiers","volume":"10","author":"Calleja","year":"2022","journal-title":"Chemistry"},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0115","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.antiviral.2017.11.001","article-title":"Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein","volume":"149","author":"Lei","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0120","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020106275","article-title":"Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2","volume":"39","author":"Klemm","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0125","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-020-2601-5","article-title":"Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity","volume":"587","author":"Shin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0130","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41467-021-21060-3","article-title":"Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors","volume":"12","author":"Osipiuk","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.antiviral.2014.12.015","article-title":"The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds","volume":"115","author":"B\u00e1ez-Santos","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0140","doi-asserted-by":"crossref","first-page":"eabd4596","DOI":"10.1126\/sciadv.abd4596","article-title":"Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti\u2013COVID-19 drug design","volume":"6","author":"Rut","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101077","article-title":"Deubiquitinating enzymes (DUBs): Regulation, homeostasis, and oxidative stress response","volume":"297","author":"Snyder","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0150","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41564-021-00884-1","article-title":"ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity","volume":"6","author":"Liu","year":"2021","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0155","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1038\/s41467-023-38031-5","article-title":"Dual domain recognition determines SARS-CoV-2 PLpro selectivity for human ISG15 and K48-linked di-ubiquitin","volume":"14","author":"Wydorski","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0160","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1126\/science.adm9724","article-title":"Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model","volume":"383","author":"Tan","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0165","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1038\/s41467-025-56902-x","article-title":"Design of quinoline SARS-CoV-2 papain-like protease inhibitors as oral antiviral drug candidates","volume":"16","author":"Jadhav","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0170","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1016\/j.apsb.2024.04.011","article-title":"Discovery and characterization of novel potent non-covalent small molecule inhibitors targeting papain-like protease from SARS-CoV-2","volume":"14","author":"Zheng","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0175","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1038\/s41467-025-59922-9","article-title":"Identification of naturally occurring drug-resistant mutations of SARS-CoV-2 papain-like protease","volume":"16","author":"Tan","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1013468","article-title":"Divergent resistance pathways amongst SARS-CoV-2 PLpro inhibitors highlight the need for scaffold diversity","volume":"21","author":"Wu","year":"2025","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0185","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/128_2011_225","article-title":"Combining biophysical screening and X-ray crystallography for fragment-based drug discovery","volume":"317","author":"Hennig","year":"2012","journal-title":"Top. Curr. Chem."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0190","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1107\/S2059798324000329","article-title":"Fragment-based screening targeting an open form of the SARS-CoV-2 main protease binding pocket","volume":"80","author":"Huang","year":"2024","journal-title":"Acta crystallographica Section D, Structural biology"},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0195","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1107\/S2052252524012247","article-title":"Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening","volume":"12","author":"Huang","year":"2025","journal-title":"IUCrJ"},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0200","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.drudis.2020.06.023","article-title":"The rise of molecular simulations in fragment-based drug design (FBDD): an overview","volume":"25","author":"Bissaro","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0205","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1021\/acsmedchemlett.4c00238","article-title":"Fragment-Based Screen of SARS-CoV-2 Papain-like Protease (PLpro)","volume":"15","author":"Taylor","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0210","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1107\/S2059798325006801","article-title":"XFBLD-Platform: a crystallographic fragment-screening platform at Shanghai Synchrotron Radiation Facility","volume":"81","author":"Huang","year":"2025","journal-title":"Acta Crystallogr. Sect. D"},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0215","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s41365-023-01348-3","article-title":"BL02U1: the relocated macromolecular crystallography beamline at the Shanghai Synchrotron Radiation Facility","volume":"34","author":"Liu","year":"2023","journal-title":"Nucl. Sci. Tech."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0220","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s41365-023-01350-9","article-title":"The biosafety level-2 macromolecular crystallography beamline (BL10U2) at the Shanghai Synchrotron Radiation Facility","volume":"34","author":"Xu","year":"2023","journal-title":"Nucl. Sci. Tech."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0225","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1107\/S1600576719001183","article-title":"Aquarium: an automatic data-processing and experiment information management system for biological macromolecular crystallography beamlines","volume":"52","author":"Yu","year":"2019","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0230","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1107\/S0021889801017824","article-title":"The Computational Crystallography Toolbox: crystallographic algorithms in a reusable software framework","volume":"35","author":"Grosse-Kunstleve","year":"2002","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0235","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1107\/S0021889809045701","article-title":"xia2: an expert system for macromolecular crystallography data reduction","volume":"43","author":"Winter","year":"2010","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0240","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1107\/S0907444911007773","article-title":"Data processing and analysis with the autoPROC toolbox","volume":"67","author":"Vonrhein","year":"2011","journal-title":"Acta Crystallogr. Sect. D"},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0245","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41467-020-20718-8","article-title":"The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery","volume":"12","author":"Fu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0250","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15123","article-title":"A multi-crystal method for extracting obscured crystallographic states from conventionally uninterpretable electron density","volume":"8","author":"Pearce","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0255","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. Sect. D"},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0260","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. Sect. D"},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0265","series-title":"The PyMOL molecular graphics system","author":"DeLano","year":"2002"},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0270","doi-asserted-by":"crossref","first-page":"W5","DOI":"10.1093\/nar\/gkaf361","article-title":"PLIP 2025: introducing protein\u2013protein interactions to the protein\u2013ligand interaction profiler","volume":"53","author":"Schake","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0275","series-title":"Approaches to Fragment-Based Drug Design, A comparison between fragment optimization methods","author":"Bonnema","year":"2022"},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0280","doi-asserted-by":"crossref","first-page":"6198","DOI":"10.1038\/s41467-025-60561-3","article-title":"Accelerating fragment-based drug discovery using grand canonical nonequilibrium candidate Monte Carlo","volume":"16","author":"Poole","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0285","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1021\/acscentsci.1c00519","article-title":"Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay","volume":"7","author":"Ma","year":"2021","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0290","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.apsb.2020.08.014","article-title":"Crystal structure of SARS-CoV-2 papain-like protease","volume":"11","author":"Gao","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0295","article-title":"Boltz-1 Democratizing Biomolecular Interaction Modeling","author":"Wohlwend","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0300","first-page":"2900","article-title":"A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID. Nature","volume":"16","author":"S","year":"2025","journal-title":"Communications"},{"key":"10.1016\/j.ijbiomac.2026.150689_bb0305","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/s41467-023-37254-w","article-title":"Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2","volume":"14","author":"Sanders","year":"2023","journal-title":"Nat. Commun."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302600615X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302600615X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:38:34Z","timestamp":1777484314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014181302600615X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":61,"alternative-id":["S014181302600615X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.150689","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crystallographic fragment screening discovers novel micromolar active inhibitors and druggable hotspots of SARS-CoV-2 PLpro","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.150689","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150689"}}